Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study.
Saved in:
| Title: | Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study. |
|---|---|
| Authors: | Robertson CA; Scientific & Medical Affairs, Sanofi, Swiftwater, PA, USA., Jacqmein J; Jacksonville Center for Clinical Research, Jacksonville, FL, USA., Selmani A; Biostatistics, Sanofi, Swiftwater, PA, USA., Galarza K; Scientific & Medical Affairs, Sanofi, Swiftwater, PA, USA., Oster P; Global Medical Affairs, Sanofi, Lyon, France. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Dec 31; Vol. 19 (1), pp. 2160600. Date of Electronic Publication: 2023 Jan 11. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36632042 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Robertson+CA%22">Robertson CA</searchLink>; Scientific & Medical Affairs, Sanofi, Swiftwater, PA, USA.<br /><searchLink fieldCode="AU" term="%22Jacqmein+J%22">Jacqmein J</searchLink>; Jacksonville Center for Clinical Research, Jacksonville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Selmani+A%22">Selmani A</searchLink>; Biostatistics, Sanofi, Swiftwater, PA, USA.<br /><searchLink fieldCode="AU" term="%22Galarza+K%22">Galarza K</searchLink>; Scientific & Medical Affairs, Sanofi, Swiftwater, PA, USA.<br /><searchLink fieldCode="AU" term="%22Oster+P%22">Oster P</searchLink>; Global Medical Affairs, Sanofi, Lyon, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101572652%22">Human vaccines & immunotherapeutics</searchLink> [Hum Vaccin Immunother] 2023 Dec 31; Vol. 19 (1), pp. 2160600. <i>Date of Electronic Publication: </i>2023 Jan 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2164-554X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221645515%22">21645515 </searchLink><i>NLM ISO Abbreviation: </i>Hum Vaccin Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36632042 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/21645515.2022.2160600 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2160600 Titles: – TitleFull: Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Robertson CA – PersonEntity: Name: NameFull: Jacqmein J – PersonEntity: Name: NameFull: Selmani A – PersonEntity: Name: NameFull: Galarza K – PersonEntity: Name: NameFull: Oster P IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 12 Text: 2023 Dec 31 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2164-554X Numbering: – Type: volume Value: 19 – Type: issue Value: 1 Titles: – TitleFull: Human vaccines & immunotherapeutics Type: main |
| ResultId | 1 |